Search





Search





Markets
/
Stocks
/
cytk
/

Cytokinetics Inc

CYTK

Add to Watchlist

77.130USD

-3.290-4.09%

Close 07-31 16:00（ET）Quotes delayed by 15 min

10.46BMarket Cap

LossP/E TTM

Cytokinetics Inc

77.130

-3.290-4.09%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

10.00

Change

The current institutional shareholding score of Cytokinetics Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 109.63%, representing a quarter-over-quarter decrease of 17.29%. The largest institutional shareholder is Steven Cohen, holding a total of 534.93K shares, representing 0.50% of shares outstanding, with 8.27% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

17.72M

-7.15%

BlackRock Institutional Trust Company, N.A.

13.99M

+2.80%

Fidelity Management & Research Company LLC

9.47M

+0.42%

Wellington Management Company, LLP

7.94M

+7.13%

State Street Investment Management (US)

5.83M

+3.70%

Deep Track Capital LP

3.34M

-22.40%

Geode Capital Management, L.L.C.

3.06M

+0.52%

BofA Global Research (US)

2.88M

-4.42%